These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28927406)

  • 21. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
    Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
    Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein A-V level may contribute to the development of obesity-associated dyslipidemia.
    Yoshino Y; Okada T; Abe Y; Odaka M; Kuromori Y; Yonezawa R; Iwata F; Mugishima H
    Obes Res Clin Pract; 2013; 7(5):e415-9. PubMed ID: 24304484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
    Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
    J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.
    Kim M; Kim M; Yoo HJ; Lee E; Chae JS; Lee SH; Lee JH
    PLoS One; 2017; 12(12):e0186693. PubMed ID: 29211729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.
    Bogari NM; Aljohani A; Amin AA; Al-Allaf FA; Dannoun A; Taher MM; Elsayed A; Rednah DI; Elkhatee O; Porqueddu M; Alamanni F; Khogeer SAA; Fawzy A
    BMC Cardiovasc Disord; 2019 Jan; 19(1):2. PubMed ID: 30606120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Apolipoprotein E gene expression in peripheral blood monocyte in children with obesity].
    Xiang W; Ma YL; Chen C; Fu SM; Yang JF; Zhao SP; Guo DX; Zhao DC; Nie S; Wang FL
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):755-60. PubMed ID: 14731357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
    Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
    Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region.
    OʼBrien SE; Schrodi SJ; Ye Z; Brilliant MH; Virani SS; Brautbar A
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):183-8. PubMed ID: 25900265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metformin reduces plasma triglycerides in ob/ob obese mice via inhibiting the hepatic apoA5 expression].
    Huang X; Li R; Chen L; Dai W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 42(12):1389-1394. PubMed ID: 29317579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic determination of dyslipidemia - What tell us the results of genome-wide association studies?].
    Hubáček JA
    Vnitr Lek; 2016; 62(11):868-876. PubMed ID: 28128572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
    Do R; Stitziel NO; Won HH; Jørgensen AB; Duga S; Angelica Merlini P; Kiezun A; Farrall M; Goel A; Zuk O; Guella I; Asselta R; Lange LA; Peloso GM; Auer PL; ; Girelli D; Martinelli N; Farlow DN; DePristo MA; Roberts R; Stewart AF; Saleheen D; Danesh J; Epstein SE; Sivapalaratnam S; Hovingh GK; Kastelein JJ; Samani NJ; Schunkert H; Erdmann J; Shah SH; Kraus WE; Davies R; Nikpay M; Johansen CT; Wang J; Hegele RA; Hechter E; Marz W; Kleber ME; Huang J; Johnson AD; Li M; Burke GL; Gross M; Liu Y; Assimes TL; Heiss G; Lange EM; Folsom AR; Taylor HA; Olivieri O; Hamsten A; Clarke R; Reilly DF; Yin W; Rivas MA; Donnelly P; Rossouw JE; Psaty BM; Herrington DM; Wilson JG; Rich SS; Bamshad MJ; Tracy RP; Cupples LA; Rader DJ; Reilly MP; Spertus JA; Cresci S; Hartiala J; Tang WH; Hazen SL; Allayee H; Reiner AP; Carlson CS; Kooperberg C; Jackson RD; Boerwinkle E; Lander ES; Schwartz SM; Siscovick DS; McPherson R; Tybjaerg-Hansen A; Abecasis GR; Watkins H; Nickerson DA; Ardissino D; Sunyaev SR; O'Donnell CJ; Altshuler D; Gabriel S; Kathiresan S
    Nature; 2015 Feb; 518(7537):102-6. PubMed ID: 25487149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.
    Zhai G; Wen P; Guo L; Chen L
    Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of apolipoprotein A5 gene variants with metabolic syndrome in Tunisian population.
    Kefi R; Hechmi M; Dallali H; Elouej S; Jmel H; Halima YB; Nagara M; Chargui M; Fadhel SB; Romdhane S; Kamoun I; Turki Z; Abid A; Bahri S; Bahlous A; Gomis R; Baraket A; Grigorescu F; Normand C; Jamoussi H; Abdelhak S
    Ann Endocrinol (Paris); 2017 Jul; 78(3):146-155. PubMed ID: 28624160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses.
    Ibi D; Boot M; Dollé MET; Jukema JW; Rosendaal FR; Christodoulides C; Neville MJ; Koivula R; Rensen PCN; Karpe F; Noordam R; Willems van Dijk K
    J Lipid Res; 2022 May; 63(5):100193. PubMed ID: 35278410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.
    Zhang X; Qi Q; Bray GA; Hu FB; Sacks FM; Qi L
    Am J Clin Nutr; 2012 Oct; 96(4):917-22. PubMed ID: 22914552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects.
    Domínguez-Reyes T; Astudillo-López CC; Salgado-Goytia L; Muñoz-Valle JF; Salgado-Bernabé AB; Guzmán-Guzmán IP; Castro-Alarcón N; Moreno-Godínez ME; Parra-Rojas I
    Lipids Health Dis; 2015 Sep; 14():106. PubMed ID: 26365669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.